Summary
We have examined the effects of the potassium conductance enhancer cromakalim (BRL 34915) and the calcium entry blocker nimodipine upon 5-hydroxytryptamine (5-HT) induced contractions in ring preparations from rabbit basilar and mesenteric arteries, and from pig coronary arteries. Cumulative concentration-response (CR) curves to 5-HT were biphasic in basilar and mesenteric arteries, and monophasic in coronary arteries. Coronary artery 5-HT CR curves and the first component of the mesenteric artery 5-HT CR curve were antagonized by ketanserin (pK B values 8.9 and 8.8, respectively), whereas basilar artery CR curves were not. Prazosin antagonized the second component of the mesenteric 5-HT CR curve, but not that of the basilar artery. Cromakalim (0.1–10 μmol/1) and nimodipine (0.001–1 μmol/l) both caused reductions in resting tension in basilar and coronary arteries denuded of their endothelia, but this effect was not seen with mesenteric arteries. Procaine (5 mmol/1) abolished this vasorelaxant effect of cromakalim in basilar artery. Both agents concentration-dependently depressed the 5-HT CR curve in coronary artery, the effect of cromakalim was antagonized by lidocaine (100 μmol/1). In basilar artery, only the first component was cromakalim sensitive unlike nimodipine which depressed both components of the CR curve. In mesenteric artery, 5-HT CR curves were depressed by cromakalim, but only slightly affected by nimodipine (1 μmol/l). It is concluded that cromakalim, like nimodipine, possesses anti-vasospastic activity; however, differences exist in the sensitivity of the 5-HT mediated contractions of the three arterial preparations to the agents. Thus, although both cromakalim and nimodipine may have potential in the treatment of subarachnoidal haemorrhage and angina pectoris, differences in their therapeutic profiles are also likely to be found.
Similar content being viewed by others
References
Allen GS (1985) Role of calcium antagonists in cerebral arterial spasms. Am J Cardiol 55: 149B–153B
Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonism. Br J Pharmacol 14:48–58
Bevan JA (1979) Transient responses of rabbit cerebral blood vessels to norepinephrine correlation with intrinsic myogenic tone. Circ Res 45:566–572
Bevan JA (1983) Diltiazem selectively inhibits cerebrovascular extrinsic but not intrinsic tone. A review. Circ Res 52:104–109
Bevan JA, Hwa JJ, Owen MP, Winquist RJ (1985) Calcium and myogenic or stretch-dependent vascular tone. In: Rubin RP (ed) Calcium in biological systems. Plenum, New York, pp 391–398
Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986a) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacol 25:563–576
Bradley PB, Humphrey PPA, Williams RH (1986b) Evidence for the existence of 5-hydroxytryptamine receptors, which are not of the 5-HT2 type, mediating contraction of rabbit isolated basilar artery. Br J Pharmacol 87:3–4
Bray KM, Weston AIL McHarg AD, Newgreen DT, Southerton JS (1988a) Comparison of the inhibitory effects of BRL 34915 and nifedipine on noradrenaline- and KCl-induced contractions in rabbit aorta. Br J Pharmacol 93:205P
Bray KM, Weston AH, McHarg AD, Newgreen DT, Southerton JS (1988b) Analysis of the inhibitory action of BRL34915 on responses to noradrenaline in rabbit aorta. Br J Pharmacol 93:206P
Buckingham RE, Clapham JC, Coldwell MC, Hamilton TC, Hewlett DR (1984) Differences in vascular effects of BRL 34915 and nifedipine in vitro. IUPHAR 9th International Congress of Pharmacology, London (Macmillan Press Ltd., Lond), Abstract: 1702
Buckingham RE, Clapham JC, Hamilton TC, Longman SE, Norton J, Poyser RH (1986) BRL34915, a novel antihypertensive agent: Comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models. J Cardiovasc Pharmacol 8:798–804
Cain C, Nicholson CD (1988) A comparison of the effects of cromakalim (BRL34915) on basilar, coronary and mesenteric arteries. Br J Pharmacol 93:208 P
Clague RU, Whiting RL (1986) 5-Hydroxytryptamine-1 and 5-hydroxytryptamine-2 receptors in the isolated pig coronary artery preparation. Br J Pharmacol 87:132P
Cocks TM, Angus JA (1983) Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 305:627–630
Cook NS, Hof RP (1988) Cardiovascular effects of apamin and BRL34915 in rats and rabbits. Br J Pharmacol 93:121–131
Cook NS, Quast U, Hof RP, Baumlin Y, Pally C (1988 a) Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915. J Cardiol Pharmacol 11:90–99
Cook NS, Weir SW, Danzeisen MC (1988 b) Anti-vasoconstrictor effects of the K+ channel opener cromakahm on the rabbit aorta — comparison with the calcium antagonist isradipine. Br J Pharmacol 95:741–752
Dawson DC, van Driessche W, Helman SI (1988) Osmotically induced basolateral K+ conductance in turtle colon: lidocaine-induced K+ noise. Am J Physiol 254:165–174
Doxey JC, Smith CFC, Walker JM (1977) Selectivity of blocking agents for pre- and postsynaptic alpha-adrenoceptors. Br J Pharmacol 60: 91–96
Drew GM (1985) What do antagonists tell us about α-adrenoceptors? Clinical Sci 68:15–19
Duckles SP, Bevan JA (1976) Pharmacological characterization of adrenergic receptors of a rabbit cerebral artery in vitro. J Pharmacol Exp Ther 197:371–378
Endo M, Hirosawa K, Kaneko N, Hase K, Inoue Y, Konno S (1976) Prinzmetal's variant angina: coronary anteriogram and left ventriculogram during angina attack induced by methacholine. New Eng J Med 294:252–255
Fujiwara S, Kuriyama H (1983) Effects of agents that modulate potassium permeability on smooth muscle cells of the guinea pig basilar artery. Br J Pharmacol 79:23–35
Garland CJ (1987) The role of membrane depolarization in the contractile response of the rabbit basilar artery to 5-hydroxytryptamine. J Physiol (Lond) 392:333–348
Garland CJ, McPherson GA (1988) Phenoxybenzamine-resistant smooth muscle depolarization and contraction with noradrenaline in the rabbit isolated basilar artery. J Physiol (Lond) 400:55P
Hamilton TC, Weir SW, Weston AH (1986) Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol 88:103–111
Humphrey PPA (1978) The effects of α-adrenoceptor antagonists on contractile responses to 5-hydroxytryptamine in dog saphenous vein. Br J Pharmacol 63:671–675
Kaumann AJ (1983) Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5-HTZ receptors. Naunyn-Schmiedeberg's Arch Pharmacol 323:149–154
Keatinge WR (1976) Effects of local anaesthetics on electrical activity and voltage-dependent K-permeability of arteries. Colloq Inst Nall Same Rech Med (1975) In: Worcel M, Vassort G (eds) Smooth muscle pharmacology and physiology 50, pp 177–182
MacKay D (1978) How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated? J Pharm Pharmacol 30:312–313
Müller-Schweinitzer E, Neuman P (1983) In vitro effects of calcium antagonists PN 200–110, nifedipine, and nimodipine on human and canine cerebral arteries. J Cereb Blood Flow Metabol 3:354–361
Parodi O, Maseri A, Simonetti I (1979) Management of unstable angina at rest by verapamil. Br Heart J 41:167–174
Purdy RE, Murray DL, Stupecky GL (1987) Receptors for 5-hydroxytryptamine in rabbit blood vessels: activation of alpha adrenoceptors in rabbit thoracic aorta. J Pharmacol Exp Ther 240:535–541
Towart R (1981) The selective inhibition of serotonin-induced contractions of rabbit cerebral vascular smooth muscle by calcium antagonist dihydropyridines. Circ Res 48:650–657
Vanhoutte PM (1983) 5-Hydroxytryptamine and vascular disease. Fed Proc 42:233–236
Vanhoutte PM, Cohen RA (1983) Calcium entry blockers and cardiovascular disease. Am J Cardiol 52:99A–103A
Van Nueten JM (1983) 5-Hydroxytryptamine and precapillary vessels. Fed Proc 42:223–227
Van Nueten JM, Janssen PAJ, Van Beek J, Xhonneaux R, Verbeuren TJ, Vanhoutte PM (1981) Vascular effects of ketanserin (R41468), a novel antagonist of 5-HTZ serotonergic receptors. J Pharmacol Exp Ther 218:217–230
Weir SW, Weston AH (1986) The effects of BRL34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels. Br J Pharmacol 88:121–128
Wilcken DEL (1982) Myogenic factors in the determination of coronary vascular resistance. In: Kalsner S (ed) The coronary artery. Croom Helm, London and Canberra, pp 292–308
Yamanaka K, Furukawa K, Kitamura K (1985) The different mechanisms of action of nicorandil and adenosine triphosphate on potassium channels of circular smooth muscle of the guinea-pig small intestine. Naunyn-Schmiedeberg's Arch Pharmacol 331:96–103
Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S (1979) Exertional angina pectoris caused by coronary arterial spasm: effects of various drugs. Am J Cardiol 43:647–652
Author information
Authors and Affiliations
Additional information
Send offprint requests to C. R. Cain at the above address
Rights and permissions
About this article
Cite this article
Cain, C.R., Nicholson, C.D. Comparison of the effects of cromakalim, a potassium conductance enhancer, and nimodipine, a calcium antagonist, on 5-hydroxytryptamine responses in a variety of vascular smooth muscle preparations. Naunyn-Schmiedeberg's Arch Pharmacol 340, 293–299 (1989). https://doi.org/10.1007/BF00168513
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00168513